The American Red Cross and the Office of the U.S. Surgeon General are warning that the nation’s blood supply has reached crisis levels after donations dropped to a four-year summer low. The organization said it now has less than a 1-day national supply of O-positive blood, the most frequently transfused blood type, forcing it to limit shipments to hospitals to preserve available inventory for the most urgent cases.

The Red Cross reported that blood donations have failed to keep pace with seasonal demand, which typically increases during the summer as travel, outdoor activities, and accidents contribute to a greater need for transfusions. According to the organization, extreme heat, poor air quality, and widespread foodborne illnesses have discouraged donations and reduced the number of eligible donors.

Officials warned that if the shortage continues, hospitals could face delays in surgeries, trauma care, cancer treatments, and other procedures that rely on a steady blood supply. The Red Cross described the situation as only the second national blood supply crisis it has declared, following a similar emergency during the COVID-19 pandemic in early 2022, and is urging eligible Americans to donate as soon as possible.

Blood cannot be manufactured, stockpiled indefinitely, or replaced with another medicine when hospitals run low. Trauma patients, women experiencing childbirth complications, cancer patients, and people undergoing surgery may need multiple units within hours.

With less than a one-day supply of O-positive blood available, even a localized emergency could force hospitals to ration inventory or postpone procedures to preserve blood for the most critical cases…

Have you ever seen Rener Gracie fight?

He is 41 years old, third-generation Brazilian Jiu-Jitsu. His family invented the sport. And he spent three decades choking people unconscious and having his joints cranked sideways by 220-pound athletes.

His wife Eve won two WWE Divas Championships. She spent years getting slammed into canvas for a living.

And recently, they both wrote seven-figure checks to a tiny medical startup nobody's heard of.

Why?

Because after fifty years of combat sports, their cartilage is grinding down to bone. And the pharmaceutical industry has nothing real to offer them.

It's the same story for half a billion people. Osteoarthritis. The cartilage wears away and never grows back. The drugs — $560 billion worth of them — just numb the pain while the joint keeps deteriorating.

Which is why a startup in Florida caught my attention. The company is called Cytonics. Their researchers found a specific protein the human body already produces to protect cartilage. Then they genetically engineered a version they say is 200% more potent… and built a therapy that targets the root cause of the disease, not the symptoms.

Phase 1 safety trials just finished. Zero adverse events. Over 10,000 patients have already used the first-generation treatment.

Meanwhile, something unusual happened. Cytonics opened a Regulation CF offering. That means ordinary investors can buy in alongside the pro-athletes and 7,000 backers already invested.*

Click here to check out their offer

Blood products have relatively short shelf lives, so hospitals naturally depend on a steady flow of donors rather than occasional surges. Various factors, ranging from extreme heat to poor air quality, have disrupted a steady supply of donors at an unfortunate time when seasonal demand is rising.

O-positive blood is widely used, and shortages often spread across hospital networks. Restoring their reserves to a comfortable amount will require sustained donations, not temporary surges, especially while summer conditions continue to suppress turnout. 

The shortage could have detrimental consequences. Serious car crashes, emergency surgeries, and childbirth complications are just a few scenarios that depend on blood being immediately available. If hospitals have fewer units on hand, doctors may have to delay non-emergency procedures, transfer patients to other facilities, and certainly conserve blood supplies for the most critical cases.

The shortage is also a reminder that the nation’s blood supply depends almost entirely on volunteer donors. Unlike many medical supplies, blood cannot be produced in a factory or imported quickly to counteract shortages like these. Maintaining an adequate supply requires consistent donations throughout the year. The more plentiful the blood supply, the better prepared hospitals are to respond to both everyday medical needs as well as large-scale emergencies and natural disasters.

Disclaimer: This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://invest.cytonics.com. Forward-looking statements are subject to risks and uncertainties. There is no guarantee of performance. Past performance does not predict future results. All investments involve risk, including loss of principal.